![Adrian Rawcliffe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adrian Rawcliffe
Director/Board Member at
WAVE LIFE SCIENCES LTD.
Net worth: 2 637 $ as of 31/05/2026
Profile
Adrian Rawcliffe is currently Chief Executive Officer at Etiome, Inc. since 2026, Chief Executive Officer & Director at Adaptimmune Ltd. since 2019, Director at Morphotek, Inc., Independent Director at Wave Life Sciences Ltd. since 2017, Director at Wave Life Sciences USA, Inc., and Chief Financial Officer at Human Genome Sciences, Inc. since 2012.
Former roles include Chief Executive Officer & Director at Adaptimmune Therapeutics Plc from 2019 to 2025, Managing Partner at GSK Equity Investments Ltd. from 2005 to 2006, Senior Vice President-Finance at GSK Plc from 2011 to 2015, Senior Vice President-Finance at GlaxoSmithKline Biologicals SA, and Principal at AlgoRx Pharmaceuticals, Inc. Education includes an undergraduate degree from the University of Durham, conferred in 1993.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 11/04/2025 | 2,371,362 ( 0.15% ) | 2 371 $ | 31/05/2026 | |
| 17/01/2025 | 44,327 ( 0.02% ) | 266 $ | 31/05/2026 | |
| 27/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Adrian Rawcliffe active positions
| Companies | Position | Start |
|---|---|---|
| WAVE LIFE SCIENCES LTD. | Director/Board Member | 01/02/2017 |
Morphotek, Inc.
 Morphotek, Inc. BiotechnologyHealth Technology Develops oncology therapies | Director/Board Member | - |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Director of Finance/CFO | 30/07/2012 |
Wave Life Sciences USA, Inc.
 Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Provides nucleic acid therapeutics | Director/Board Member | - |
Adaptimmune Ltd.
 Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Focuses on the use of T cell therapy to treat cancer and infectious diseases | Chief Executive Officer | 01/09/2019 |
Flagship Labs 84, Inc.
 Flagship Labs 84, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines | Chief Executive Officer | 08/01/2026 |
Former positions of Adrian Rawcliffe
| Companies | Position | End |
|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Chief Executive Officer | 14/11/2025 |
| GSK PLC | Corporate Officer/Principal | 01/01/2015 |
AlgoRx Pharmaceuticals, Inc.
 AlgoRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs for pain management | Corporate Officer/Principal | 18/02/2009 |
| ░░░ ░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Adrian Rawcliffe
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
77
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Morphotek, Inc.
Morphotek, Inc. BiotechnologyHealth Technology Develops oncology therapies | Health Technology |
Wave Life Sciences Ltd.
 Wave Life Sciences Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA oligonucleotides medicines | Health Technology |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Finance |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
GlaxoSmithKline Biologicals SA
 GlaxoSmithKline Biologicals SA BiotechnologyHealth Technology Operates biopharma and pharmaceutical company | Health Technology |
AlgoRx Pharmaceuticals, Inc.
AlgoRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs for pain management | Health Technology |
University of Durham
 University of Durham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptimmune Ltd.
Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Focuses on the use of T cell therapy to treat cancer and infectious diseases | Health Services |
Adaptimmune Therapeutics Plc
 Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
Wave Life Sciences USA, Inc.
Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Provides nucleic acid therapeutics | Utilities |
Flagship Labs 84, Inc.
Flagship Labs 84, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines | Health Technology |
- Stock Market
- Insiders
- Adrian Rawcliffe
